Literature DB >> 29857280

Small molecule-induced cellular fate reprogramming: promising road leading to Rome.

Xiang Li1, Jun Xu2, Hongkui Deng3.   

Abstract

Cellular fate reprogramming holds great promise to generate functional cell types for replenishing new cells and restoring functional loss. Inspired by transcription factor-induced reprogramming, the field of cellular reprogramming has greatly advanced and developed into divergent streams of reprogramming approaches. Remarkably, increasing studies have shown the power and advantages of small molecule-based approaches for cellular fate reprogramming, which could overcome the limitations of conventional transgenic-based reprogramming. In this concise review, we discuss these findings and highlight the future potentiality with particular focus on this new trend of chemical reprogramming.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2018        PMID: 29857280     DOI: 10.1016/j.gde.2018.05.004

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  11 in total

Review 1.  Tumorigenicity risk of iPSCs in vivo: nip it in the bud.

Authors:  Chaoliang Zhong; Miao Liu; Xinghua Pan; Haiying Zhu
Journal:  Precis Clin Med       Date:  2022-02-03

2.  NOTCH1 signaling regulates the latent neurogenic program in adult reactive astrocytes after spinal cord injury.

Authors:  Zijian Tan; Shangyao Qin; Yimin Yuan; Xin Hu; Xiao Huang; Hong Liu; Yingyan Pu; Cheng He; Zhida Su
Journal:  Theranostics       Date:  2022-05-27       Impact factor: 11.600

3.  Reprogramming of fibroblasts into expandable cardiovascular progenitor cells via small molecules in xeno-free conditions.

Authors:  Jia Wang; Shanshan Gu; Fang Liu; Zihao Chen; He Xu; Zhun Liu; Weisheng Cheng; Linwei Wu; Tao Xu; Zhongyan Chen; Ding Chen; Xuena Chen; Fanzhu Zeng; Zhiju Zhao; Mingliang Zhang; Nan Cao
Journal:  Nat Biomed Eng       Date:  2022-03-31       Impact factor: 29.234

Review 4.  Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era.

Authors:  Birbal Singh; Gorakh Mal; Vinod Verma; Ruchi Tiwari; Muhammad Imran Khan; Ranjan K Mohapatra; Saikat Mitra; Salem A Alyami; Talha Bin Emran; Kuldeep Dhama; Mohammad Ali Moni
Journal:  Stem Cell Res Ther       Date:  2021-05-12       Impact factor: 6.832

Review 5.  Impelling force and current challenges by chemicals in somatic cell reprogramming and expansion beyond hepatocytes.

Authors:  Jian-Yun Ge; Yun-Wen Zheng; Li-Ping Liu; Hiroko Isoda; Tatsuya Oda
Journal:  World J Stem Cells       Date:  2019-09-26       Impact factor: 5.326

Review 6.  Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.

Authors:  Kenly Wuputra; Chia-Chen Ku; Deng-Chyang Wu; Ying-Chu Lin; Shigeo Saito; Kazunari K Yokoyama
Journal:  J Exp Clin Cancer Res       Date:  2020-06-03

7.  In vivo chemical reprogramming of astrocytes into neurons.

Authors:  Yantao Ma; Handan Xie; Xiaomin Du; Lipeng Wang; Xueqin Jin; Qianqian Zhang; Yawen Han; Shicheng Sun; Longteng Wang; Xiang Li; Changjiang Zhang; Mengdi Wang; Cheng Li; Jun Xu; Zhuo Huang; Xiaoqun Wang; Zhen Chai; Hongkui Deng
Journal:  Cell Discov       Date:  2021-03-02       Impact factor: 10.849

8.  Conversion of Fibroblast into Functional Leydig-like Cell Using Defined Small Molecules.

Authors:  Yan Yang; Chenxing Zhou; Tiantian Zhang; Quan Li; Jiaxin Mei; Jinlian Liang; Ziyi Li; Hanhao Li; Qi Xiang; Qihao Zhang; Lei Zhang; Yadong Huang
Journal:  Stem Cell Reports       Date:  2020-07-30       Impact factor: 7.765

9.  Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.

Authors:  Xiugong Gao; Rong Li; Patrick Cahan; Yang Zhao; Jeffrey J Yourick; Robert L Sprando
Journal:  Stem Cell Res Ther       Date:  2020-09-11       Impact factor: 6.832

Review 10.  Bioactive Molecules for Skin Repair and Regeneration: Progress and Perspectives.

Authors:  Deyun Chen; Qian Hou; Lingzhi Zhong; Yali Zhao; Meirong Li; Xiaobing Fu
Journal:  Stem Cells Int       Date:  2019-12-31       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.